Biotech Showcase™ 2016: Interview: Novaseek looks to boost R&D efficiency

February 11, 2016
Novaseek Research CEO Kate Torchilin outlines to “The Pink Sheet” senior writer Emily Hayes the key drivers behind development of her company’s Novaseek Clinical Data Network for Research (CDNR) platform, which provides access to real-world clinical data and human biospecimens for use in trials. The tool processes clinical data in a way that is fully compliant with the Health Insurance Portability and Accountability Act. Researchers become knowledgeable about patients treated in US hospitals, helping to really inform their R&D programs and substantially improve on them, Torchilin explains. The exec also discusses the challenges of getting biospecimens and how the platform could help researchers identify the right specimens from the right patients at the right time, with the overall goal of improving R&D efficiency and productivity. Find more videos and articles at http://www.partnering360.com/insight For more information on Biotech Showcase™, visit our webpage: http://www.ebdgroup.com/bts/index.php
Previous Video
Biotech Showcase™ 2016: KPI Therapeutics chief explains company's virtual business model
Biotech Showcase™ 2016: KPI Therapeutics chief explains company's virtual business model

KPI Therapeutics president and CEO Dr. Charles Magness explains to Mike Ward, Informa Pharma Insights globa...

Next Video
Biotech Showcase™ 2016: Interview: Cenna puts its own spin on trusted amyloid beta target
Biotech Showcase™ 2016: Interview: Cenna puts its own spin on trusted amyloid beta target

Amyloid beta is a well-established target in Alzheimer’s disease, and yet there have been many failures in ...